Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Adaptive Biotechnologies Corporation (ADPT)

34.16   0.36 (1.07%) 02-21 16:00
Open: 33.55 Pre. Close: 33.8
High: 34.59 Low: 33.55
Volume: 785,240 Market Cap: 4278M
Adaptive Biotechnologies Corporation develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions that inform current and future clinical trials, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 34.593 - 34.714 34.714 - 34.824
Low: 33.204 - 33.359 33.359 - 33.501
Close: 33.914 - 34.13 34.13 - 34.328

Technical analysis

as of: 2020-02-21 4:27:26 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 40.40     One year: 47.19
Support: Support1: 29.43    Support2: 26.25
Resistance: Resistance1: 34.59    Resistance2: 40.40
Pivot: 31.58
Moving Average: MA(5): 32.94     MA(20): 31.38
MA(100): 29.30     MA(250):
MACD: MACD(12,26):     Signal(9): 0.68
Stochastic oscillator: %K(14,3): 94.14     %D(3): 85.81
RSI: RSI(14): 68.16
52-week: High: 55.12  Low: 24.05  Change(%): -15.2
Average Vol(K): 3-Month: 114927  10-Days: 83874

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ADPT has closed below upper band by 3.2%. Bollinger Bands are 13.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 01 Feb 2020 14:00:00 +0000
Why Is Microsoft Investing in Adaptive Biotechnologies?

Wed, 08 Jan 2020 12:00:00 +0000
Here’s Why Illumina Shares Barely Budged When It Gave Up On Its Takeover to The Tune Of $98 Million

Tue, 10 Dec 2019 16:18:19 +0000
2 Top Small-Cap Stocks to Buy in December

Fri, 28 Jun 2019 21:59:00 +0000
US IPO Weekly Recap: Big biotechs score big as Adaptive soars 142%

Wed, 14 Aug 2019 18:06:05 +0000
Health Care Sector Update for 08/14/2019: ADPT,CHNG,TLRY

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 125.24
Shares Float (M) 68.20
% Held by Insiders 5.57
% Held by Institutions 66.58
Shares Short (K) 4970
Shares Short P. Month (K)

Stock Financials

EPS -1.510
Book Value (p.s.) 4.710
PEG Ratio
Profit Margin -78.49
Operating Margin -87.56
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth 51.6
Gross Profit (p.s.) -0.025
Sales Per Share
EBITDA (p.s.) -0.487
Qtrly Earnings Growth
Operating Cash Flow (M) 226.78
Levered Free Cash Flow (M)

Stock Valuations

P/E -22.62
P/E Growth Ratio 0.01
P/BV 7.25
P/S 18.07
P/CF 18.86

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.